关注
Maria Guarino
标题
引用次数
引用次数
年份
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study
HCCNIS Fabio Piscaglia, Gianluca Svegliati‐Baroni, Andrea Barchetti, Anna ...
Hepatology, 2016
5962016
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
The Lancet, 2018
4682018
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study
Journal of Hepatology, 2014
224*2014
Development and validation of a new prognostic system for patients with hepatocellular carcinoma
PLoS Med 13 (4), e1002006, 2016
1372016
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
A Cucchetti, F Trevisani, A Pecorelli, V Erroi, F Farinati, F Ciccarese, ...
Journal of Hepatology 61 (2), 333-341, 2014
1352014
Curcumin and Fennel Essential Oil Improve Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome
AG Piero Portincasa, Leonilde Bonfrate, Maria Lia Scribano, Anna Kohn ...
J Gastrointestin Liver Dis 25 (2), 151-157, 2016
1232016
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice.
Hepatology (Baltimore, Md.), 2017
114*2017
Hepatic Decompensation is the Major Driver of Death In HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
Journal of Hepatology, 2017
1002017
Sustained virological response: a milestone in the treatment of chronic hepatitis C.
F Morisco, R Granata, M Guarino, L Donnarumma, L Gaeta, I Loperto, ...
World J Gastroenterol 19 (18), 2793-2798, 2013
982013
Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon
Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017
932017
A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma
CC Giuseppe Cabibbo, Salvatore Petta, Marco Barbàra, Gabriele Missale ...
Liver International, 2017
892017
Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use
EG Giannini, G Sammito, F Farinati, F Ciccarese, A Pecorelli, ...
Cancer 120 (14), 2150-2157, 2014
822014
The evolutionary scenario of hepatocellular carcinoma in Italy: an update
Liver International, 2016
79*2016
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma
The American journal of gastroenterology, 2016
76*2016
Comparison between alcohol‐and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome
Alimentary pharmacology & therapeutics, 2015
70*2015
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
FM Maria Guarino, Anna Sessa, Valentina Cossiga, Federica Morando, Nicola ...
World journal of gastroenterology 24 (24), 2582, 2018
642018
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma
Liver International, 2016
54*2016
Measuring calcitonin in washout of the needle in patients undergoing fine needle aspiration with suspicious medullary thyroid cancer
P Trimboli, F Rossi, R Baldelli, O Laurenti, G Nigri, C Ventura, ...
Diagnostic Cytopathology 40 (5), 394-398, 2012
522012
Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades
NC Filomena Morisco, Ilaria Loperto, Tommaso Stroffolini, Flavia Lucia ...
Journal of medical virology 89 (2), 291-297, 2017
512017
Osteoporosis across chronic liver disease.
FM M Guarino, I Loperto, S Camera, V Cossiga, Carolina Di Somma, A Colao, N ...
Osteoporosis International 27 (6), 1967-1977, 2016
472016
系统目前无法执行此操作,请稍后再试。
文章 1–20